News October 10, 2022 Congress reauthorizes the SBIR/STTR Programs | SBIR.gov WASHINGTON – Administrator Isabella Casillas Guzman, head of the U.S. Small Business Administration and voice… Super User 0 Love0
News October 10, 2022 Industry Leaders Share Optimism on the Region’s Life Sciences Economic Outlook Amid Recession Concerns · BioBuzz It’s no secret that a recession could hit the United States before the year ends.… Super User 0 Love0
News October 10, 2022 51 “Build to Scale” Grants Totaling $47 Million Awarded to Fuel Innovation and Tech-Based Economic Development Today, the U.S. Economic Development Administration awarded 51 “Build to Scale” grants – totaling $47… Super User 0 Love0
News October 5, 2022 Richmond Times-Dispatch: Inside greater Richmond’s big plan for pharmaceutical manufacturing The Richmond area is planning a major pharmaceutical manufacturing initiative to build drugs here, restore the nation’s… Super User 0 Love0
News October 5, 2022 NextCure Announces Initiation of Phase 1b/2 Clinical Trial to Evaluate NC410 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Immune Checkpoint Refractory or Naïve Solid Tumors BELTSVILLE, Md., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed… Super User 0 Love0
BHI Weekly News Archives October 5, 2022 527th Edition, October 5, 2022 Trouble Viewing This Email: Click Here October 5, 2022 FOUNDING MEMBER OF miRecule… Super User 0 Love0
News October 5, 2022 Commerce secretary, local experts (Including BHI’s Sarah Miller) project how recession would affect life sciences | Biotech | fredericknewspost.com Is there a recession on the horizon? Some economists say yes — and predict it’s… Super User 0 Love0
News October 4, 2022 BioHealth Executive-In-Residence Montgomery County, MD BioHealth Innovation, Inc. (BHI) has partnered with Montgomery County, Maryland to support entrepreneurs seeking to… Super User 0 Love0
News October 4, 2022 miRecule Enters into Strategic Collaboration with Sanofi to Accelerate Discovery and Development of a Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy (FSHD) | Business Wire Partnership combines miRecule’s unique RNA therapeutic discovery and conjugation platforms with Sanofi’s NANOBODY® technology to… Super User 0 Love0
News October 4, 2022 Gaithersburg’s Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial October 04, 2022 08:29 AM Eastern Daylight Time GAITHERSBURG, Md--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”),… Super User 0 Love0